The Limits and Potential Future Applications of Personalized Medicine to Prevent Complex Chronic Disease

The milestone sequencing of the human genome more than a decade ago dawned a genomic revolution with the potential of transforming health. The anticipated benefits included the identification of the early biomarkers of disease, the ability to combine information on risk-conferring genes to improve r...

Full description

Saved in:
Bibliographic Details
Published inPublic health reports (1974) Vol. 133; no. 5; pp. 519 - 522
Main Authors Bergquist, Sharon Horesh, Lobelo, Felipe
Format Journal Article
LanguageEnglish
Published Los Angeles, CA ASSOCIATION OF SCHOOLS & PROGRAMS OF PUBLIC HEALTH 01.09.2018
SAGE Publications
SAGE PUBLICATIONS, INC
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The milestone sequencing of the human genome more than a decade ago dawned a genomic revolution with the potential of transforming health. The anticipated benefits included the identification of the early biomarkers of disease, the ability to combine information on risk-conferring genes to improve risk prediction, and the discovery of new disease pathways that can serve as the target for novel therapeutics. Despite monumental breakthroughs, however, genomic science is in its infancy. A gap remains between science and patient benefit. A growing concern is that for the term "personalized medicine" has become a proxy for DNA-centered approaches to prevention and treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0033-3549
1468-2877
DOI:10.1177/0033354918781568